SC
IDXX icon

Solstein Capital’s Idexx Laboratories IDXX Stock Holding History

Solstein Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.42K Hold
16
– – ﹤0.01% 339
2026
Q1 		$8.99K Hold
16
– – ﹤0.01% 340
2025
Q4 		$10.8K Hold
16
– – ﹤0.01% 324
2025
Q3 		$10.2K Hold
16
– – ﹤0.01% 330
2025
Q2 		$8.58K Buy
+16
New +$7.65K ﹤0.01% 349
2020
Q2 		– Sell
-7
Closed -$2K – 261
2020
Q1 		$2K Buy
+7
New +$1.83K 0.01% 231

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Solstein Capital's IDXX Position: Q2 2026 in Review

Solstein Capital held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 16 shares worth $8.42K. The position accounts for ﹤0.01% of the portfolio, ranked #339.

Solstein Capital first reported a position in IDXX in Q1 2020 and has held it in 6 quarters since. The position peaked at $10.8K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Solstein Capital held 16 shares of Idexx Laboratories worth $8.42K as of Q2 2026.
  • Solstein Capital left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Solstein Capital's portfolio in Q2 2026, its #339 holding.
  • Solstein Capital first reported a position in Idexx Laboratories in Q1 2020 and has held it in 6 quarters since.
  • Solstein Capital's Idexx Laboratories position peaked at $10.8K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Solstein Capital's 13F filing for Q2 2026, filed 13 Aug 2026.